Data on the exact proportion of PC patients with BRCA mutations come from a 2018 systematic review and meta-analysis by Mok et al. They showed that the frequency of BRCA1 and BRCA2 carriers in PC patients was 0.9% and 2.2%, respectively [11]. The gene discussed is BRCA2; the disease is pachyonychia congenita.